Stem Competitors

OTC Stocks . USA . 
Stock . Stem Holdings
STMH Stock  USD 0.0001  0.00  0.00%   
Stem Holdings competes with Grown Rogue; as well as few others. The company conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Stem Holdings competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Stem Holdings to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Stem Holdings Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Stem Holdings competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00009850.01
Details
Intrinsic
Valuation
LowRealHigh
0.000.00007450.01
Details
Naive
Forecast
LowNextHigh
0.0000020.0001222.03
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Stem Holdings Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Stem Holdings and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Stem and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Stem Holdings does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
FFNTF
+ 0.6
GRUSF
CNTMF
+ 0.49
GRUSF
FFNTF
+ 0.23
KAYS
SHWZ
+ 0.13
KAYS
SHWZ
+ 0.09
FFNTF
SGMD
+ 0.08
SHWZ
  
High negative correlations   
CNTMF
- 0.65
KAYS
GRUSF
- 0.18
KAYS
SGMD
- 0.15
GRUSF
FFNTF
- 0.08
CNTMF
SGMD
- 0.06
CNTMF
SHWZ
- 0.06
GRUSF

Risk-Adjusted Indicators

There is a big difference between Stem OTC Stock performing well and Stem Holdings OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Stem Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Stem Holdings Competitive Analysis

The better you understand Stem Holdings competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Stem Holdings' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Stem Holdings' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
STMH MPXOF KAYS GRUSF CNTMF FFNTF SHWZ SGMD
 0.00 
 0.0001 
Stem
 0.00 
 0.0001 
MPX
 13.04 
 0.02 
Kaya
 5.00 
 0.38 
Grown
 12.86 
 0.06 
Cansortium
 90.91 
 0.0001 
4Front
 809.09 
 0.02 
Medicine
 0.00 
 0.0001 
Sugarmade
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Out of control
Out of control
Out of control
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Good
Very Weak
Very Weak
Very Weak
Modest
OK
Solid
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Below Average
Quite High
Low
Low
Quite High
Average
Below Average
Above Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
1.25 X
0.47 X
0.02 X
1.61 X
0.73 X
0.74 X
2.34 X
0.16 X
Net Asset
30.98 M
50.67 M
1.57 M
14.21 M
182.46 M
255.54 M
285.03 M
16.87 M
Profit Margin
(1.05) %
N/A
N/A
0.06 %
(0.29) %
(0.32) %
0.15 %
(1.50) %
EBITDA
(13.47 M)
(16.01 M)
11.26 M
(193.65 K)
11.66 M
(4.02 M)
34.51 M
(9.37 M)
Operating Margin
(0.75) %
(2.56) %
(1.57) %
0.20 %
0.08 %
(0.15) %
0.13 %
(1.16) %
Current Valuation
13.19 M
18.4 M
8.85 M
21.02 M
118.5 M
433.05 M
180.81 M
12.1 M
Price To Book
0.18 X
0.19 X
N/A
3.47 X
0.96 X
5.13 X
0.47 X
0.35 X
Retained Earnings
N/A
N/A
(10.89 M)
N/A
N/A
N/A
N/A
(23.85 M)
Current Asset
N/A
N/A
105 K
N/A
N/A
N/A
N/A
692 K
Beta
0.95
0.82
0.24
0.51
3.37
1.81
1.92
0.0373
Number Of Employees
150
5
4
11
10
464
389
7
Shares Outstanding
238.5 M
144.32 M
14.72 M
170.63 M
225.38 M
640.39 M
54.74 M
12.51 B
Cash Flow From Operations
(6.47 M)
(8.13 M)
(1.04 M)
(238.46 K)
(5.03 M)
5.78 M
57.33 M
(3.68 M)
Total Debt
1.23 M
7.47 M
7.18 M
1.37 M
53.67 M
64.62 M
97.48 M
5.76 M
Return On Equity
-0.65
-1.64
N/A
0.26
-0.28
-0.74
0.16
-3.01
Z Score
1.8
N/A
13.5
8.4
N/A
1.2
N/A
-1.4
Return On Asset
-0.18
-0.22
-0.47
0.15
0.021
-0.0398
0.0452
-0.17
Book Value Per Share
0.07 X
0.05 X
(1.22) X
0.04 X
0.15 X
0.08 X
2.90 X
N/A
Current Liabilities
N/A
N/A
2.92 M
N/A
N/A
N/A
N/A
4.07 M
Total Asset
30.98 M
50.67 M
1.57 M
14.21 M
182.46 M
255.54 M
285.03 M
16.87 M
Debt To Equity
0.43 %
2.56 %
N/A
0.53 %
1.89 %
3.72 %
0.87 %
4.00 %
Target Price
26.97
N/A
N/A
0.54
1.7
2.37
2.23
N/A
Shares Owned By Institutions
0.12 %
N/A
N/A
16.71 %
0.51 %
4.59 %
0.73 %
N/A
Market Capitalization
4.77 M
540.18 K
1.05 M
20.48 M
33.24 M
151.58 M
72.37 M
1.25 M
Price To Earning
N/A
N/A
0.72 X
N/A
N/A
N/A
N/A
(1.14) X
Price To Sales
0.14 X
0.08 X
1.33 X
1.01 X
0.41 X
1.83 X
0.49 X
0.47 X
Net Income
(17.37 M)
(26.63 M)
9.72 M
(1.01 M)
(19.04 M)
(38.31 M)
14.52 M
(11.07 M)
Earnings Per Share
(0.27) X
(0.15) X
0.09 X
(0.01) X
(0.1) X
(0.06) X
(0.69) X
(0) X
Shares Owned By Insiders
1.84 %
14.09 %
16.28 %
22.76 %
20.98 %
34.18 %
26.48 %
10.11 %
Revenue
16.56 M
7.21 M
889.9 K
9.38 M
65.44 M
104.57 M
108.42 M
4.72 M
Working Capital
N/A
N/A
(2.82 M)
N/A
N/A
N/A
N/A
(3.38 M)
Cash And Equivalents
3.4 M
2.36 M
46.6 K
1.53 M
8.86 M
6.03 M
33.86 M
148.24 K
Cash Per Share
0.01 X
0.02 X
N/A
0.01 X
0.04 X
0.01 X
0.62 X
N/A
Gross Profit
2.12 M
3.98 M
610.57 K
6.1 M
35.79 M
49.4 M
49.35 M
2.79 M
Day Typical Price
1.0E-4
1.0E-4
0.0165
0.39
0.0643
1.0E-4
0.02
1.0E-4
Accumulation Distribution
N/A
N/A
0.0909
0.05
0.14
0.5
N/A
N/A
Market Facilitation Index
N/A
N/A
0.0016
0.02
0.01
1.0E-4
N/A
N/A
Daily Balance Of Power
0.0
0.0
(1.50)
(1.00)
(0.90)
(10.00)
9.2 T
0.0
Period Momentum Indicator
N/A
N/A
(0)
(0.02)
(0.01)
(0)
0.0178
N/A
Rate Of Daily Change
1.0
1.0
0.87
0.95
0.87
0.0909
9.09
1.0
Day Median Price
1.0E-4
1.0E-4
0.0168
0.39
0.066
1.0E-4
0.02
1.0E-4
Price Action Indicator
N/A
N/A
(0)
(0.02)
(0.01)
(0.0006)
0.0089
N/A
Relative Strength Index
51.01
N/A
37.19
50.21
49.36
41.52
52.54
52.85
Coefficient Of Variation
493.4
N/A
(982.67)
(2,003)
1614.89
723.14
574.07
613.58
Mean Deviation
95.5
N/A
6.06
3.08
6.1
52.66
402.42
63.64
Jensen Alpha
30.84
N/A
(0.87)
(0.26)
0.5772
18.83
218.91
29.46
Total Risk Alpha
1.78
N/A
(2.52)
(1.04)
(1.13)
(7.38)
(25.43)
(5.74)
Sortino Ratio
N/A
N/A
N/A
N/A
0.0447
0.4068
3.42
N/A
Downside Variance
N/A
N/A
N/A
N/A
66.41
1942.78
4008.88
N/A
Standard Deviation
222.03
N/A
8.48
4.22
8.45
130.81
1245.55
181.06
Kurtosis
16.12
N/A
1.5
(0.16)
1.4
50.48
58.55
27.27
Potential Upside
N/A
N/A
13.29
5.88
15.38
100.0
809.09
N/A
Treynor Ratio
0.4736
N/A
20.11
(0.78)
(1.20)
(3.59)
(16.56)
121.59
Maximum Drawdown
1100.0
N/A
50.58
17.18
41.67
1090.91
9989.0
1100.0
Variance
49296.61
N/A
71.87
17.78
71.46
17110.21
1551406.79
32781.42
Market Risk Adjusted Performance
0.4836
N/A
20.12
(0.77)
(1.19)
(3.58)
(16.55)
121.6
Risk Adjusted Performance
0.1651
N/A
(0.07)
(0.03)
0.0565
0.1158
0.1433
0.1347
Skewness
4.16
N/A
(0.22)
(0.06)
0.8133
6.7
7.49
5.29
Semi Deviation
N/A
N/A
N/A
N/A
6.75
32.39
46.33
N/A
Information Ratio
0.202
N/A
(0.12)
(0.09)
0.0431
0.1371
0.1741
0.1621
Value At Risk
N/A
N/A
(13.70)
(7.50)
(11.54)
(62.50)
(83.50)
N/A
Expected Short fall
N/A
N/A
N/A
N/A
(7.46)
(89.38)
(766.94)
N/A
Downside Deviation
N/A
N/A
N/A
N/A
8.15
44.08
63.32
N/A
Semi Variance
N/A
N/A
N/A
N/A
45.58
1048.98
2146.62
N/A

Stem Holdings Competition Performance Charts

Five steps to successful analysis of Stem Holdings Competition

Stem Holdings' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Stem Holdings in relation to its competition. Stem Holdings' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Stem Holdings in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Stem Holdings' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Stem Holdings, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Stem Holdings position

In addition to having Stem Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Food Products Thematic Idea Now

Food Products
Food Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Food Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Food Products Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Stem OTC Stock

Stem Holdings financial ratios help investors to determine whether Stem OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Holdings security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY